Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @jrouldz

$ABCL

BEARISH2026-08-10

Price around the call

↓ 2026-08-10

By horizonMaturing · ~0 trading days to go

✗ +5.8%

✗ +14.3%

21d

…

Original post

Dr J Rould · 2026-08-10

They key point for $ABCL news today is not just “one good clinical data readout” Abcellera placed a massive, high risk bet on themselves: Instead of just selling big pharma access to their drug discovery platform (a relatively straightforward, lower risk business), they took a massive leap to try and BECOME a pharma company of their own, utilizing their own platform while absorbing the extreme risk of running clinical trials Today’s news is early confirmation that their bet is paying off: • upside from here is clear • downside risk is mitigated dramatically Result = shares are rerated. Those waiting for a meaningful dip: do not get your hopes up. New paradigms usher new price floors.

View on X ↗